Wellbeing Digital Sciences Subsidiary IRP Health Approved as Part of Coveted Chronic Pain Centre of Excellence for Canadian Veterans Network

Wellbeing Digital Sciences Subsidiary IRP Health Approved as Part of Coveted Chronic Pain Centre of Excellence for Canadian Veterans Network

The Company’s Ottawa-Based IRP Health Clinic has Also Been Approved by Veterans Affairs Canada for its Reactivation Program  

Vancouver, British Columbia, April 28, 2022 / Globe Newswire / – Wellbeing Digital Sciences Inc.  (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based  mental healthcare company focused on the development and implementation of innovative clinical  solutions such as psychedelic medicine and digital therapeutics supported by clinical research, is pleased to  announce that its subsidiary, IRP Health Ltd. (“IRP Health” or the “Subsidiary”), has been approved as  part of the Chronic Pain Centre of Excellence for Canadian veterans (“CPCoE”). Additionally, IRP  Health’s clinic in Ottawa, Ontario (the “Ottawa Clinic”) has been approved by Veterans Affair Canada  (“VAC”) for its multidisciplinary Reactivation-branded therapy program (“Reactivation”).  

CPCoE  

After meeting strict criteria, IRP Health’s four Canadian locations will now be listed and recommended as  part of the national network of clinics. The clinics will contribute towards the national collection of data to  help further research and innovation with respect to the treatment of military veterans. The CPCoE provides  national leadership for research co-designed with veterans and their families and supports the  implementation of this research with a national network of clinics to help veterans and their families manage  their pain and reconnect with life.  

Thanks to CAD 20 million in funding from VAC over five years, the CPCoE strives to be a leader in  veteran-first chronic pain research and improving care.. The CPCoE is already the national leader in  researching chronic pain inveterans. Its guiding principles for research include national and international  collaborations, building upon its existing strengths in Canada, and capitalizing on the investments made by  VAC. With the goal of improving veterans’ wellbeing, the CPCoE’s research findings will be used to  promote evidence-based best practices to inform a network of pain clinics, researchers, case managers and  the public. More information can be found by visiting the following website:  https://www.veteranschronicpain.ca/  

Ottawa Clinic 

IRP Health’s Ottawa Clinic has been approved by VAC to begin offering the Reactivation therapy program  at the location. Reactivation is a 12-week, physician-supervised, interdisciplinary pain management  program that assists veterans with chronic musculoskeletal injuries and pain. It aims to help veterans return  to behaviours that are consistent with being well, rather than behaviours that are consistent with suffering.  The goals of Reactivation are to decrease distressing symptoms, increase engagement in the community  and increase the ability to complete daily tasks and also strives to reduce patient disability in both the short  and long term, while giving veterans better control and understanding of their pain and health challenges.  The therapy program combines psychiatry, psychology, occupational therapy, physiotherapy, kinesiology,  and dietetics to provide an interdisciplinary approach and a cutting-edge treatment.  

VAC is a government organization for current and former members of the Canadian Armed Forces, Royal  Canadian Mounted Police and their family members which strives to provide services and benefits intended  to improve the well-being of the veterans and their kin. The approval of the Reactivation program in the  Ottawa Clinic has the potential to make a difference in the lives of many veterans who are coping with  mental and physical illnesses. More information about VAC can be found on its website:  https://www.veterans.gc.ca/eng 

Management Commentary  

“Being recognised by Canada’s leader in chronic pain research and services for military veterans is both a  privilege and an honour. The support and guidance we have received through the CPCoE to this point has  been integral in developing our foundation for growth and we look forward to supporting them through  furthering their national data collection,” said Steven Inglefield, Chief Executive Officer of IRP Health and  Chief Operating Officer of Wellbeing.  

“We are pleased that IRP Health continues to make strides toward improving the lives of veterans and first  responders through the Reactivation program. To be recognized as being a national network of clinics that  works with Canadian veterans, IRP Health is evolving in positive ways. We are proud of the Subsidiary for  becoming part of the CPCoE and helping veterans and their families. As part of Wellbeing, IRP Health is  focused on enriching the lives of its patients and raising the bar for outstanding mental healthcare,” said  Najla Guthrie, Chief Executive Officer of Wellbeing.  

ABOUT IRP HEALTH  

Founded in 2016, IRP began as a rehabilitation and performance centre offering exercise therapy and  rehabilitation programs in Victoria, British Columbia. IRP builds safe and supportive environments while  demonstrating modern, evidence-based physical rehabilitation programs designed specifically for the needs  of veterans and first responders. Building on the success of over 15,000 treatments in the flagship Victoria  location. IRP is adding new locations and programs to improve access to much needed treatments. More  information about IRP Health can be found on its website: https://www.irphealth.ca 

ABOUT WELLBEING DIGITAL SCIENCES  

Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on the  development and implementation of innovative clinical solutions, including psychedelic medicine and  digital therapeutics, as supported by clinical research. Its mission is supported by a network of North  American clinics that provide forward-thinking therapies and other types of treatment to patients as well as  through a contract research organization that offers clinical trials services to clients pursuing drug  development. In essence, the Company exists to make breakthrough treatments more accessible and to offer  patients transformational experiences. 

On behalf of:  

WELLBEING DIGITAL SCIENCES INC. 

“Najla Guthrie” 

Najla Guthrie, CEO  

For further information, please contact:  

Nick Kuzyk, Investor Relations  

Tel: 1-844-746-6351  

Email: ir@wellbeingdigital.co  

Web: www.wellbeingdigital.co 

Twitter: @Wellbeing_IR  

Notice Regarding Forward-Looking Information: 

This news release contains forward-looking statements including but not limited to statements regarding  the Company’s business, assets or investments, as well other statements that are not historical facts. Readers  are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that  the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking  statements involve numerous assumptions, known and unknown risks and uncertainties, both general and  specific, that contribute to the possibility that the predictions, forecasts, projections and other forward 

looking statements will not occur, which may cause actual performance and results in future periods to  differ materially from any estimates or projections of future performance or results expressed or implied by  such forward-looking statements. These assumptions, risks and uncertainties include, among other things,  the state of the economy in general and capital markets in particular, investor interest in the business and  prospects of the Company.  

The forward-looking statements contained in this news release are made as of the date of this news release.  Except as required by law, the Company disclaims any intention and assumes no obligation to update or  revise any forward-looking statements, whether as a result of new information, future events or otherwise,  except as required by applicable securities law. Additionally, the Company undertakes no obligation to  comment on the expectations of, or statements made, by third parties in respect of the matters discussed  above.